TETRACAINE Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A benzoate ester in which 4-N-butylbenzoic acid and 2-(dimethylamino)ethanol have combined to form the ester bond; a local ester anaesthetic (ester caine) used for surface and spinal anaesthesia. (Chemical Entities of Biological Interest Ontology, CHEBI_9468)
External Link https://dgidb.org/results?searchType=drug&searchTerms=TETRACAINE
Similar Terms
Downloads & Tools

Genes

11 interacting proteins for the TETRACAINE drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
SCN10A sodium channel, voltage gated, type X alpha subunit 0.105758
SCN7A sodium channel, voltage gated, type VII alpha subunit 0.0815593
SCN11A sodium channel, voltage gated, type XI alpha subunit 0.0729091
SCN3A sodium channel, voltage gated, type III alpha subunit 0.0659178
SCN4A sodium channel, voltage gated, type IV alpha subunit 0.0633158
SCN2A sodium channel, voltage gated, type II alpha subunit 0.0633158
SCN8A sodium channel, voltage gated, type VIII alpha subunit 0.0624935
SCN1A sodium channel, voltage gated, type I alpha subunit 0.0616923
SCN9A sodium channel, voltage gated, type IX alpha subunit 0.0506526
G6PD glucose-6-phosphate dehydrogenase 0.048606
SCN5A sodium channel, voltage gated, type V alpha subunit 0.0453962